Y-Intercept (HK)
BBOT icon

Y-Intercept (HK)’s BridgeBio Oncology BBOT Stock Holding History

Y-Intercept (HK)’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$159K Buy
+38,846
New +$302K ﹤0.01% 1495

Other funds holding BBOT

Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Toth Financial Advisory
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Y-Intercept (HK)'s BBOT Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in BridgeBio Oncology (BBOT) in Q3 2026: 38,846 shares worth $159K. The stake represents ﹤0.01% of the portfolio and ranks #1495 among its holdings.

4 funds tracked by Wall St. Rank hold BBOT as of Q3 2026.

  • Y-Intercept (HK) held 38,846 shares of BridgeBio Oncology worth $159K as of Q3 2026.
  • BridgeBio Oncology was a new Y-Intercept (HK) position in Q3 2026.
  • BridgeBio Oncology made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1495 holding.
  • 4 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.